These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 16142740)

  • 1. Aromatase inhibitors and the syndrome of arthralgias with estrogen deprivation.
    Felson DT; Cummings SR
    Arthritis Rheum; 2005 Sep; 52(9):2594-8. PubMed ID: 16142740
    [No Abstract]   [Full Text] [Related]  

  • 2. Joint pain with aromatase inhibitors: abnormal frequency of Sjögren's syndrome.
    Laroche M; Borg S; Lassoued S; De Lafontan B; Roché H
    J Rheumatol; 2007 Nov; 34(11):2259-63. PubMed ID: 17937464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aromatase inhibitor-associated arthralgia syndrome.
    Burstein HJ
    Breast; 2007 Jun; 16(3):223-34. PubMed ID: 17368903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Should urogenital atrophy in breast cancer survivors be treated with topical estrogens?
    Trinkaus M; Chin S; Wolfman W; Simmons C; Clemons M
    Oncologist; 2008 Mar; 13(3):222-31. PubMed ID: 18378532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aromatase inhibitors and arthralgias: a new frontier in symptom management for breast cancer survivors.
    Burstein HJ; Winer EP
    J Clin Oncol; 2007 Sep; 25(25):3797-9. PubMed ID: 17761968
    [No Abstract]   [Full Text] [Related]  

  • 6. Getting a grip on aromatase inhibitor-associated arthralgias.
    Hershman DL
    J Clin Oncol; 2008 Jul; 26(19):3120-1. PubMed ID: 18474872
    [No Abstract]   [Full Text] [Related]  

  • 7. [Arthralgias during menopause: pathogenic connections].
    Bartl R
    Dtsch Med Wochenschr; 2010 Sep; 135(36):1757-8. PubMed ID: 20812164
    [No Abstract]   [Full Text] [Related]  

  • 8. Role of oestrogen in the development of joint symptoms?
    Tan AL; Emery P
    Lancet Oncol; 2008 Sep; 9(9):817-8. PubMed ID: 18760239
    [No Abstract]   [Full Text] [Related]  

  • 9. Aromatase inhibitor-associated arthralgias.
    Chlebowski RT
    J Clin Oncol; 2009 Oct; 27(30):4932-4. PubMed ID: 19752332
    [No Abstract]   [Full Text] [Related]  

  • 10. Aromatase inhibitor-induced arthralgia: is vitamin D deficiency responsible?
    Prieto-Alhambra D; Javaid MK
    Maturitas; 2011 May; 69(1):3-4. PubMed ID: 21277123
    [No Abstract]   [Full Text] [Related]  

  • 11. Aromatase inhibitors: potential reproductive implications.
    Bedaiwy MA; Mousa NA; Casper RF
    J Minim Invasive Gynecol; 2009; 16(5):533-9. PubMed ID: 19608462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aromatase in the context of breast and endometrial cancer. A review.
    Jongen VH; Hollema H; Van Der Zee AG; Heineman MJ
    Minerva Endocrinol; 2006 Mar; 31(1):47-60. PubMed ID: 16498363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term effects of treatment-induced hormonal changes on cognitive function in breast cancer patients: results of a multicenter, prospective, longitudinal study.
    Hermelink K; Henschel V; Untch M; Bauerfeind I; Lux MP; Munzel K
    Cancer; 2008 Nov; 113(9):2431-9. PubMed ID: 18823033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aromatase inhibitors in breast cancer.
    Hiscox S; Davies EL; Barrett-Lee P
    Maturitas; 2009 Aug; 63(4):275-9. PubMed ID: 19577386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intratumoral estrogens and estrogen receptors in human non-small cell lung carcinoma.
    Niikawa H; Suzuki T; Miki Y; Suzuki S; Nagasaki S; Akahira J; Honma S; Evans DB; Hayashi S; Kondo T; Sasano H
    Clin Cancer Res; 2008 Jul; 14(14):4417-26. PubMed ID: 18579664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of estrogen deprivation on gene expression profiles of normal postmenopausal breast tissue in vivo.
    Kendall A; Anderson H; Dunbier AK; Mackay A; Dexter T; Urruticoechea A; Harper-Wynne C; Dowsett M
    Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):855-63. PubMed ID: 18398027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aromatase inhibitor and bone.
    Miki Y; Suzuki T; Sasano H
    Biomed Pharmacother; 2007 Oct; 61(9):540-2. PubMed ID: 17904790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aromatase inhibitor-induced joint pain: melatonin's role.
    Burk R
    Med Hypotheses; 2008 Dec; 71(6):862-7. PubMed ID: 18782656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The potential adverse effects of aromatase inhibitors on wound healing: in vitro and in vivo evidence.
    Howgate DJ; Gamie Z; Panteliadis P; Bhalla A; Mantalaris A; Tsiridis E
    Expert Opin Drug Saf; 2009 Sep; 8(5):523-35. PubMed ID: 19645634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arthralgia and aromatase inhibitors.
    Wendling D; Letho-Gyselinck H; Guillot X; Prati C; Pivot X
    Joint Bone Spine; 2014 Mar; 81(2):187-8. PubMed ID: 23953220
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.